Roche releases recalled eye implant in US
Genentech said it has resumed sales of its Susvimo eye implant in the United States following the end of a voluntary recall, and the device will become available to patients in the coming weeks. The implant was approved by the US health regulator in 2021 to treat a chronic condition that causes blurred vision.
BELIEBTE BEITRÄGE
Colombia was the deadliest country for environmentalists in 2023
September 11, 2024
Floods inundate northern Vietnam, Typhoon Yagi death toll rises
September 11, 2024
Destin Daniel Cretton in talks to direct ‘Spider-Man 4’
September 11, 2024
LIVEÜBERTRAGUNG